Xenon to Present at Upcoming Investor Conferences GlobeNewswire - Wed Nov 13, 3:01PM CST
GlobeNewswire
Wed Nov 13, 3:01PM CST
Xenon Reports Q3 2024 Financial Results and Business Update GlobeNewswire - Tue Nov 12, 3:01PM CST
GlobeNewswire
Tue Nov 12, 3:01PM CST
Xenon to Report Q3 2024 Financial Results on November 12, 2024 GlobeNewswire - Tue Nov 5, 3:01PM CST
GlobeNewswire
Tue Nov 5, 3:01PM CST
Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress GlobeNewswire - Mon Sep 9, 7:30AM CDT
GlobeNewswire
Mon Sep 9, 7:30AM CDT
Xenon Reports Q2 2024 Financial Results and Business Update GlobeNewswire - Thu Aug 8, 3:01PM CDT
GlobeNewswire
Thu Aug 8, 3:01PM CDT
Xenon to Report Q2 2024 Financial Results on August 8, 2024 GlobeNewswire - Thu Aug 1, 3:01PM CDT
GlobeNewswire
Thu Aug 1, 3:01PM CDT
The Globe Investing Club 2024: Let the competition begin! The Globe and Mail - Fri May 17, 3:04PM CDT
The Globe and Mail
Fri May 17, 3:04PM CDT
The challenge is not just about beating the competition, we want to spark discussion about investing and all the different factors that can lift – and pummel – share prices
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days GlobeNewswire - Tue Mar 12, 3:01PM CDT
GlobeNewswire
Tue Mar 12, 3:01PM CDT
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024 GlobeNewswire - Mon Jan 8, 7:00AM CST
GlobeNewswire
Mon Jan 8, 7:00AM CST
Tuesday’s analyst upgrades and downgrades The Globe and Mail - Tue Dec 19, 2023
The Globe and Mail
Tue Dec 19, 2023
Inside the Market’s roundup of some of today’s key analyst actions
